Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratio

BACKGROUND: The significant reduction of angiographic restenosis rates in the ISAR-SWEET study (intracoronary stenting and antithrombotic regimen: is abciximab a superior way to eliminate elevated thrombotic risk in diabetes) raises the question of whether abciximab acts on clopidogrel-independent m...

Descripción completa

Detalles Bibliográficos
Autores principales: Voisard, Rainer, Alan, Mustafa, Müller, Lutz von, Baur, Regine, Hombach, Vinzenz
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475639/
https://www.ncbi.nlm.nih.gov/pubmed/16595000
http://dx.doi.org/10.1186/1471-2261-6-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475639/
https://www.ncbi.nlm.nih.gov/pubmed/16595000
http://dx.doi.org/10.1186/1471-2261-6-14

Ejemplares similares